Overview
Tibial aplasia-ectrodactyly syndrome is a rare congenital limb malformation disorder characterized by the absence or severe underdevelopment (aplasia or hypoplasia) of the tibia (the larger bone of the lower leg) combined with ectrodactyly, also known as split hand/split foot malformation (SHFM). Ectrodactyly involves the absence of one or more central digits of the hands and/or feet, often resulting in a characteristic cleft or lobster-claw appearance. The condition primarily affects the skeletal and musculoskeletal systems, with limb abnormalities that can be bilateral or unilateral and may vary in severity even within the same family. Affected individuals typically present at birth with shortened or absent tibiae, leading to significant lower limb deformity and impaired mobility. The split hand/foot malformation can affect both upper and lower extremities. Additional features may include absence or hypoplasia of the fibula in some cases, though the hallmark combination is tibial deficiency with ectrodactyly. The condition is generally not associated with intellectual disability or major internal organ involvement, though thorough evaluation is recommended to rule out associated anomalies. Treatment is primarily supportive and surgical. Orthopedic interventions may include limb reconstruction, prosthetic fitting, and corrective surgeries to improve function and mobility. Hand surgery may be considered to optimize grip and hand function. A multidisciplinary approach involving orthopedic surgeons, prosthetists, physical therapists, and genetic counselors is recommended. Genetic counseling is important for affected families given the hereditary nature of the condition. No curative therapy currently exists, and management focuses on maximizing functional independence and quality of life.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Tibial aplasia-ectrodactyly syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Tibial aplasia-ectrodactyly syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Tibial aplasia-ectrodactyly syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Tibial aplasia-ectrodactyly syndrome.
Community
No community posts yet. Be the first to share your experience with Tibial aplasia-ectrodactyly syndrome.
Start the conversation →Latest news about Tibial aplasia-ectrodactyly syndrome
No recent news articles for Tibial aplasia-ectrodactyly syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Tibial aplasia-ectrodactyly syndrome
What is Tibial aplasia-ectrodactyly syndrome?
Tibial aplasia-ectrodactyly syndrome is a rare congenital limb malformation disorder characterized by the absence or severe underdevelopment (aplasia or hypoplasia) of the tibia (the larger bone of the lower leg) combined with ectrodactyly, also known as split hand/split foot malformation (SHFM). Ectrodactyly involves the absence of one or more central digits of the hands and/or feet, often resulting in a characteristic cleft or lobster-claw appearance. The condition primarily affects the skeletal and musculoskeletal systems, with limb abnormalities that can be bilateral or unilateral and may
How is Tibial aplasia-ectrodactyly syndrome inherited?
Tibial aplasia-ectrodactyly syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Tibial aplasia-ectrodactyly syndrome typically begin?
Typical onset of Tibial aplasia-ectrodactyly syndrome is neonatal. Age of onset can vary across affected individuals.